## SHW: Sherwin-Williams Company (The) - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -1.8% below STRENGTH zone (3.0-6.0%); PEG 3.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($325.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Sherwin-Williams (SHW): Evaluating Valuation After Earnings Beat and Suvinil Acquisition Boost Outlook**
- Source: Simply Wall Street | 20251202T023602 | Bullish | Relevance: 99%
- Sherwin-Williams (SHW) reported strong third-quarter earnings and revenue, beating expectations, with an improved outlook following the Suvinil acquisition. While analysts suggest it's undervalued at $341.49 against a $386.52 fair value, the company's P/E ratio of 32.7x is higher than the industry average, prompting a debate on whether the market has fully priced in future growth. The article presents differing views on valuation and potential risks.

**2. Mizuho Lifts Sherwin-Williams (SHW) Price Target to $400 After Solid Q3 Results**
- Source: MSN | 20251201T170629 | Bullish | Relevance: 99%
- Mizuho increased its price target for Sherwin-Williams (SHW) to $400 from $375, maintaining a "Buy" rating, following the company's strong third-quarter results. The upgrade reflects improved sales trends, resilient margins, and positive momentum from the consumer brands group, which countered weakness in architectural new residential coatings. Though the analysts anticipate a challenging fourth quarter due to unfavorable weather and ongoing B2B trends, they foresee strong growth in 2024 driven by higher volumes and an easier comparison.

**3. Sherwin-Williams (SHW) CFO exercises options, reports updated direct and indirect holdings**
- Source: Stock Titan | 20251203T182000 | Neutral | Relevance: 99%
- Sherwin-Williams' (SHW) SVP of Finance & CFO, Allen J. Mistysyn, exercised employee stock options for 338 shares at $295.83 and 464 shares at $215.08 on December 1, 2025. The filing also detailed dispositions of shares to cover taxes and updated direct ownership to 13,273â€“13,562 shares, including restricted stock units, along with indirect holdings through a 401(k) plan, a trust, and a spouse. After these transactions, the CFO retains 15,662 and 14,336 remaining stock options from grants made in October 2021 and October 2022, respectively.

**4. 1832 Asset Management L.P. Sells 164,830 Shares of The Sherwin-Williams Company $SHW**
- Source: MarketBeat | 20251203T081259 | Somewhat-Bullish | Relevance: 99%
- 1832 Asset Management L.P. reduced its stake in The Sherwin-Williams Company (NYSE:SHW) by 17.4% in the second quarter, selling 164,830 shares and now owning 784,091 shares valued at $269.23 million. Other institutional investors also made changes to their positions. The article also covers analyst ratings, stock performance data, and recent earnings announcements for Sherwin-Williams.

**5. New York State Common Retirement Fund Sells 1,100 Shares of The Sherwin-Williams Company $SHW**
- Source: MarketBeat | 20251201T193711 | Somewhat-Bullish | Relevance: 99%
- The New York State Common Retirement Fund decreased its stake in The Sherwin-Williams Company (NYSE:SHW) by 0.3%, selling 1,100 shares. The fund now holds 346,136 shares valued at approximately $118.85 million. Sherwin-Williams reported strong quarterly earnings, beating analyst estimates, and has a "Moderate Buy" consensus rating from analysts with a target price of $390.87.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 16 ($0.21M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.31 signals overvaluation risk, limited margin of safety. Forward P/E 26.8x stretched relative to 11% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $80.1B |
| Beta | 1.24 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.31 |
| Forward P/E | 26.8 |
| Current P/E | 29.8 |
| YoY Growth | 11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.5% to -1.8% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (0.75), confirming momentum. RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.82% (CS: 33) | Neutral |
| RSI_14 | 50.7 | Neutral |
| MACD Histogram | 0.75 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.003x | Above |
| vs SMA200 | 0.978x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $339.24
- **Stop Loss:** $325.64 (4.0% risk)
- **Target:** $352.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 69
- **Position Value:** $23,407.56
- **Portfolio %:** 23.41%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX at 16 is below median, showing calm, but breadth is only moderate and put/call is neutral, suggesting neither strong bullish nor defensive extremes. Key drivers are rising Fed rate-cut odds from soft ADP jobs data, mixed earnings across sectors, and ongoing AI/tech strength offset by caution in cyclicals and banks. Positioning should remain selective and neutral, awaiting more decisive macro or earnings signals.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*